glp-1 cardiovascular outcomes news today medications are not just for weight loss — they are the most important drug class of our lifetime. 🫀 A 2025 meta-analysis of 99,599 patients confirmed: ✓ 20% reduction in major GLP-1 Receptor Agonists in Heart

This provided more evidence that miR-34a plays a role in the GLP-1 mechanism that regulates the proliferation and survival of beta cells [177]

But in addition to the oral compound, the branded medications, the personalized GLP-1 doses, which augment the commercially available dosages for patients that need it as well as off-patent GLP-1s like liraglutide, I think we believe the combination of that portfolio, allows customers and providers a really robust range of offerings that we think is very durable

However, these patches were medical-grade formulations and are not comparable to commercially available over the counter supplement patches

They also include different formulations, delivery devices, and combinations with other drugs